Cargando…
Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors
In the past decade, induced pluripotent stem cells (iPSCs) technology has significantly progressed in studying malignant solid tumors. This technically feasible reprogramming techniques can reawaken sequestered dormant regions that regulate the fate of differentiated cells. Despite the evolving ther...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661832/ https://www.ncbi.nlm.nih.gov/pubmed/37755647 http://dx.doi.org/10.1007/s12015-023-10633-y |
_version_ | 1785138068932526080 |
---|---|
author | He, Rong Weng, Zhijie Liu, Yunkun Li, Bingzhi Wang, Wenxuan Meng, Wanrong Li, Bo Li, Longjiang |
author_facet | He, Rong Weng, Zhijie Liu, Yunkun Li, Bingzhi Wang, Wenxuan Meng, Wanrong Li, Bo Li, Longjiang |
author_sort | He, Rong |
collection | PubMed |
description | In the past decade, induced pluripotent stem cells (iPSCs) technology has significantly progressed in studying malignant solid tumors. This technically feasible reprogramming techniques can reawaken sequestered dormant regions that regulate the fate of differentiated cells. Despite the evolving therapeutic modalities for malignant solid tumors, treatment outcomes have not been satisfactory. Recently, scientists attempted to apply induced pluripotent stem cell technology to cancer research, from modeling to treatment. Induced pluripotent stem cells derived from somatic cells, cancer cell lines, primary tumors, and individuals with an inherited propensity to develop cancer have shown great potential in cancer modeling, cell therapy, immunotherapy, and understanding tumor progression. This review summarizes the evolution of induced pluripotent stem cells technology and its applications in malignant solid tumor. Additionally, we discuss potential obstacles to induced pluripotent stem cell technology. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10661832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-106618322023-09-27 Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors He, Rong Weng, Zhijie Liu, Yunkun Li, Bingzhi Wang, Wenxuan Meng, Wanrong Li, Bo Li, Longjiang Stem Cell Rev Rep Article In the past decade, induced pluripotent stem cells (iPSCs) technology has significantly progressed in studying malignant solid tumors. This technically feasible reprogramming techniques can reawaken sequestered dormant regions that regulate the fate of differentiated cells. Despite the evolving therapeutic modalities for malignant solid tumors, treatment outcomes have not been satisfactory. Recently, scientists attempted to apply induced pluripotent stem cell technology to cancer research, from modeling to treatment. Induced pluripotent stem cells derived from somatic cells, cancer cell lines, primary tumors, and individuals with an inherited propensity to develop cancer have shown great potential in cancer modeling, cell therapy, immunotherapy, and understanding tumor progression. This review summarizes the evolution of induced pluripotent stem cells technology and its applications in malignant solid tumor. Additionally, we discuss potential obstacles to induced pluripotent stem cell technology. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2023-09-27 2023 /pmc/articles/PMC10661832/ /pubmed/37755647 http://dx.doi.org/10.1007/s12015-023-10633-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article He, Rong Weng, Zhijie Liu, Yunkun Li, Bingzhi Wang, Wenxuan Meng, Wanrong Li, Bo Li, Longjiang Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors |
title | Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors |
title_full | Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors |
title_fullStr | Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors |
title_full_unstemmed | Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors |
title_short | Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors |
title_sort | application of induced pluripotent stem cells in malignant solid tumors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661832/ https://www.ncbi.nlm.nih.gov/pubmed/37755647 http://dx.doi.org/10.1007/s12015-023-10633-y |
work_keys_str_mv | AT herong applicationofinducedpluripotentstemcellsinmalignantsolidtumors AT wengzhijie applicationofinducedpluripotentstemcellsinmalignantsolidtumors AT liuyunkun applicationofinducedpluripotentstemcellsinmalignantsolidtumors AT libingzhi applicationofinducedpluripotentstemcellsinmalignantsolidtumors AT wangwenxuan applicationofinducedpluripotentstemcellsinmalignantsolidtumors AT mengwanrong applicationofinducedpluripotentstemcellsinmalignantsolidtumors AT libo applicationofinducedpluripotentstemcellsinmalignantsolidtumors AT lilongjiang applicationofinducedpluripotentstemcellsinmalignantsolidtumors |